资讯

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...
Durable reductions in seizures and continuing improvements in cognition and behavior through 3 years in patients who continued to receive zorevunersen in the open-label extension studies - ...
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 ...
Prolonged absence from school is most harmful to achievement at the very start and in the transitional years from primary to secondary, according to new research. The study of more than 8,000 pupils ...
U.S. INDICATIONS AND USAGE POMBILITI in combination with OPFOLDA is indicated for the treatment of adult patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency) ...
H. Lundbeck A/S (Lundbeck) is advancing leadership in migraine with a comprehensive collection of datasets to be presented at the 2025 International Headache Congress, taking place in São Paulo (Sept ...
Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress ...
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across ...
In case you've faced some hurdles solving the clue, Secondary social media accounts, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure ...
Detailed price information for Apogee Therapeutics Inc (APGE-Q) from The Globe and Mail including charting and trades.
Detailed price information for Stoke Therapeutics Inc (STOK-Q) from The Globe and Mail including charting and trades.
In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, ESC Guidelines recommend complete revascularisation – treating the main culprit blockage ...